ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > ILDR2

ILDR2

概要

Name:Immunoglobulin-like domain-containing receptor 2
Target Synonym:Immunoglobulin-like domain-containing receptor 2,ILDR2,C1orf32,Immunoglobulin-Like Domain Containing Receptor 2,LISCH-Like,DJ782G3.1,Immunoglobulin Like Domain Containing Receptor 2,Chromosome 1 Open Reading Frame 32
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

製品リスト製品比較と製品注文

製品仕様別:
製品カテゴリー別:
種類別:
タグ別:
コンジュゲート:
製造番号 種類 製品説明 構造 純度 特徴
IL2-H5259 Human Human ILDR2 Protein, Fc Tag
IL2-H5259-structure
IL2-H5259-sds
ACRO Quality

Synonym Name

ILDR2,C1orf32

Background

ILDR2 belongs to the immunoglobulin superfamily. May be involved in lipid homeostasis and ER stress pathways. ILDR2 as a novel B7-like protein with robust T cell inhibitory activity, expressed in immune cells and in immune-privileged and inflamed tissues. A fusion protein, consisting of ILDR2 extracellular domain with an Fc fragment, that binds to a putative counterpart on activated T cells showed a beneficial effect in the collagen-induced arthritis model and abrogated the production of proinflammatory cytokines and chemokines in autologous synovial-like cocultures of macrophages and cytokine-stimulated T cells. Collectively, these findings point to ILDR2 as a novel negative regulator for T cells, with potential roles in the development of immune-related diseases, including autoimmunity and cancer.

Clinical and Translational Updates

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
Bapotulimab BAY-1905254 Phase 1 Clinical Compugen Ltd Solid tumours; Squamous Cell Carcinoma of Head and Neck Details
Bapotulimab BAY-1905254 Phase 1 Clinical Compugen Ltd Solid tumours; Squamous Cell Carcinoma of Head and Neck Details

This web search service is supported by Google Inc.

totopphone